Jan Wallace

1.3k total citations
9 papers, 463 citations indexed

About

Jan Wallace is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jan Wallace has authored 9 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jan Wallace's work include Prostate Cancer Treatment and Research (3 papers), Urinary and Genital Oncology Studies (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Jan Wallace is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Urinary and Genital Oncology Studies (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Jan Wallace collaborates with scholars based in United Kingdom, United States and Switzerland. Jan Wallace's co-authors include Stephen Doxsey, Germán Pihán, Malcolm Crundwell, Peter Jenkins, Emma Hall, Nicholas D. James, Jean Tremlett, Robert Huddart, Syed A. Hussain and Rebecca Lewis and has published in prestigious journals such as Journal of Clinical Oncology, European Respiratory Journal and European Urology.

In The Last Decade

Jan Wallace

9 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Wallace United Kingdom	6	233	226	162	87	83	9	463
María Giselle Peters Argentina	10	300 1.3×	120 0.5×	177 1.1×	37 0.4×	89 1.1×	17	469
Shujie He New Zealand	9	428 1.8×	56 0.2×	109 0.7×	44 0.5×	87 1.0×	17	539
Mirko Müller Germany	11	356 1.5×	43 0.2×	90 0.6×	35 0.4×	119 1.4×	12	506
Costanza Ballarò Italy	7	263 1.1×	44 0.2×	169 1.0×	21 0.2×	77 0.9×	8	399
Asha Padar United States	8	561 2.4×	35 0.2×	119 0.7×	69 0.8×	119 1.4×	8	665
G. Landberg Sweden	8	250 1.1×	77 0.3×	115 0.7×	53 0.6×	66 0.8×	11	423
Corine L’Hôte United Kingdom	7	308 1.3×	53 0.2×	53 0.3×	99 1.1×	41 0.5×	7	394
Marja‐Riitta Väisänen Finland	11	169 0.7×	47 0.2×	97 0.6×	23 0.3×	84 1.0×	12	392
Leili Saeednejad Zanjani Iran	13	273 1.2×	75 0.3×	201 1.2×	50 0.6×	114 1.4×	37	497
Olivier Humbey France	8	220 0.9×	32 0.1×	231 1.4×	64 0.7×	81 1.0×	9	406

Countries citing papers authored by Jan Wallace

Since Specialization

Citations

This map shows the geographic impact of Jan Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Wallace more than expected).

Fields of papers citing papers by Jan Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Wallace. The network helps show where Jan Wallace may publish in the future.

Co-authorship network of co-authors of Jan Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Wallace. A scholar is included among the top collaborators of Jan Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Wallace. Jan Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hall, Emma, Syed A. Hussain, Núria Porta, et al.. (2022). Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial. European Urology. 82(3). 273–279. 59 indexed citations

Rushworth, Linda, Carolyn J. Loveridge, Mark J. Salji, et al.. (2022). Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer. British Journal of Urology. 131(2). 236–243. 5 indexed citations

Hussain, Syed A., Núria Porta, Emma Hall, et al.. (2020). Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. European Urology. 79(2). 307–315. 19 indexed citations

Derby, Sarah, et al.. (2019). Systemic anti cancer treatment for penile cancer: Real world experience of tertiary cancer centre. European Urology Supplements. 18(11). e3617–e3617. 1 indexed citations

McKay, Stephen, S. Neilson, Jan Wallace, et al.. (2017). Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer. British Journal of Urology. 121(2). 268–274. 18 indexed citations

James, Nicholas D., Matthew R. Sydes, Noel W. Clarke, et al.. (2016). Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer: Survival results from STAMPEDE (NCT00268476).. Journal of Clinical Oncology. 34(2_suppl). 162–162. 4 indexed citations

Xu, Bo, Gamze Ayata, Jan Wallace, et al.. (2006). HER-2 Status in Breast Cancer. Applied immunohistochemistry & molecular morphology. 14(2). 132–137. 34 indexed citations

Pihán, Germán, et al.. (2003). Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.. The Journal of the American Medical Association (JAMA) Network (American Medical Association). 63(6). 1398–404. 319 indexed citations

Donaldson, Nora, et al.. (2000). Sequential re-analysis of a phase-III clinical trial in non-small cell lung cancer. European Respiratory Journal. 15(5). 821–827. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact